The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 11,154 | 432,317 | SH | SOLE | N/A | 432,317 | 0 | 0 | |
ALLAKOS INC | COM | 01671P100 | 16,949 | 147,662 | SH | SOLE | N/A | 147,662 | 0 | 0 | |
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 9,987 | 1,608,237 | SH | SOLE | N/A | 1,608,237 | 0 | 0 | |
AMICUS THERAPEUTICS INC | COM | 03152W109 | 7,795 | 788,980 | SH | SOLE | N/A | 788,980 | 0 | 0 | |
ARGENX SE | SPONSORED ADR | 04016X101 | 14,169 | 51,450 | SH | SOLE | N/A | 51,450 | 0 | 0 | |
AXSOME THERAPEUTICS INC | COM | 05464T104 | 14,245 | 251,598 | SH | SOLE | N/A | 251,598 | 0 | 0 | |
CATABASIS PHARMACEUTICALS IN | COM NEW | 14875P206 | 154 | 53,166 | SH | SOLE | N/A | 53,166 | 0 | 0 | |
COGENT BIOSCIENCES INC | COM | 19240Q201 | 13,688 | 1,558,975 | SH | SOLE | N/A | 1,558,975 | 0 | 0 | |
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 8,441 | 171,147 | SH | SOLE | N/A | 171,147 | 0 | 0 | |
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 7,131 | 175,000 | SH | SOLE | N/A | 175,000 | 0 | 0 | |
INSMED INC | COM PAR $.01 | 457669307 | 32,759 | 961,797 | SH | SOLE | N/A | 961,797 | 0 | 0 | |
INSTIL BIO INC | COM | 45783C101 | 13,794 | 550,000 | SH | SOLE | N/A | 550,000 | 0 | 0 | |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 17,916 | 565,890 | SH | SOLE | N/A | 565,890 | 0 | 0 | |
KEROS THERAPEUTICS INC | COM | 492327101 | 6,729 | 109,333 | SH | SOLE | N/A | 109,333 | 0 | 0 | |
MIRATI THERAPEUTICS INC | COM | 60468T105 | 11,614 | 67,800 | SH | SOLE | N/A | 67,800 | 0 | 0 | |
SERES THERAPEUTICS INC | COM | 81750R102 | 7,269 | 353,016 | SH | SOLE | N/A | 353,016 | 0 | 0 | |
THERAPEUTICS ACQUISITION COR | COM CL A | 88339T103 | 526 | 50,000 | SH | SOLE | N/A | 50,000 | 0 | 0 | |
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 14,211 | 1,323,181 | SH | SOLE | N/A | 1,323,181 | 0 | 0 | |
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 702 | 83,944 | SH | SOLE | N/A | 83,944 | 0 | 0 | |
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 581 | 35,092 | SH | SOLE | N/A | 35,092 | 0 | 0 | |
ZOGENIX INC | COM NEW | 98978L204 | 27,431 | 1,405,259 | SH | SOLE | N/A | 1,405,259 | 0 | 0 |